Roche invests in innovation as it hires early R&D head from Sanford-Burnham
This article was originally published in Scrip
Executive Summary
The recruitment of John Reed from the Sanford-Burnham Medical Research Institute in San Diego as the head of Roche Pharma Research and Early Development (pRED) appears to be a strategic hire in line with Roche's plans for adding innovative drug and diagnostic technology from external sources to its internal research and development pipeline.